Experimental drugs take aim at obesity.
Vastag
Brian
B
D000818:Animals; D019440:Anti-Obesity Agents / Q000494:pharmacology / Q000627:therapeutic use*; D020934:Ciliary Neurotrophic Factor / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D004341:Drug Evaluation; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D000077285:Rimonabant; D014481:United States; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D020934:Ciliary Neurotrophic Factor; D003503:Cyclobutanes; D015507:Drugs, Investigational; D007783:Lactones; D010880:Piperidines; D011720:Pyrazoles; D011994:Recombinant Proteins; D000077403:Orlistat; D000077285:Rimonabant; C058254:sibutramine